T
The New York Times
Guest
Last week, for the first time in U.S. history, federal regulators approved the sale of a birth control pill without a prescription.
Pam Belluck, a health and science correspondent for The Times, explains why, after decades of brutal battles over contraception, this decision played out so differently.
Guest: Pam Belluck, a health and science correspondent for The New York Times.
Background reading:
For more information on today’s episode, visit
nytimes.com/thedaily
. Transcripts of each episode will be made available by the next workday.
Continue reading...
Pam Belluck, a health and science correspondent for The Times, explains why, after decades of brutal battles over contraception, this decision played out so differently.
Guest: Pam Belluck, a health and science correspondent for The New York Times.
Background reading:
- The F.D.A. approved a birth control pill to be sold without a prescription for the first time in the United States, a milestone that could significantly expand access to contraception.
- Here’s how women reacted to the news.
For more information on today’s episode, visit
nytimes.com/thedaily
. Transcripts of each episode will be made available by the next workday.
Continue reading...